SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,730 | -9.5% | 336 | -14.5% | 0.02% | -8.0% |
Q2 2023 | $45,006 | -91.7% | 393 | -93.4% | 0.02% | -84.1% |
Q4 2021 | $540,000 | -35.1% | 6,000 | -33.3% | 0.16% | -25.6% |
Q3 2021 | $832,000 | -23.5% | 9,000 | -35.7% | 0.21% | -28.5% |
Q2 2021 | $1,088,000 | +53.7% | 14,000 | +47.4% | 0.30% | +23.4% |
Q1 2021 | $708,000 | +471.0% | 9,500 | +1210.3% | 0.24% | +359.6% |
Q4 2020 | $124,000 | +396.0% | 725 | +314.3% | 0.05% | +333.3% |
Q3 2020 | $25,000 | – | 175 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |